Cargando…
Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
BACKGROUND: Sleep is essential for wellbeing, yet sleep disturbance is a common problem linked to a wide range of health conditions. Palmitoylethanolamide (PEA) is an endogenous fatty acid amide proposed to promote better sleep via potential interaction with the endocannabinoid system. METHODS: This...
Autores principales: | Rao, Amanda, Ebelt, Phillippa, Mallard, Alistair, Briskey, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428962/ https://www.ncbi.nlm.nih.gov/pubmed/34522787 http://dx.doi.org/10.1186/s41606-021-00065-3 |
Ejemplares similares
-
The Effect of Orally Dosed Levagen+™ (palmitoylethanolamide) on Exercise Recovery in Healthy Males—A Double-Blind, Randomized, Placebo-Controlled Study
por: Mallard, Alistair, et al.
Publicado: (2020) -
The Efficacy of Palmitoylethanolamide (Levagen+) on the Incidence and Symptoms of Upper Respiratory Tract Infection—A Double Blind, Randomised, Placebo-Controlled Trial
por: Rao, Amanda, et al.
Publicado: (2023) -
The effect of an orally‐dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: A double‐blind, randomised, placebo‐controlled study
por: Rao, Amanda, et al.
Publicado: (2021) -
A double-blind, randomised cross-over study to evaluate the absorption of a commercially available Ginkgo biloba extract compared to the liposomal extract Ginkgosome
por: Briskey, David, et al.
Publicado: (2022) -
Effects of Omeprazole on Sleep Disturbance: Randomized Multicenter Double-Blind Placebo-Controlled Trial
por: Aimi, Masahito, et al.
Publicado: (2014)